Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Elevai Labs Forms New Scientific Advisory Board for its Weight Loss Programs
-
Form 8.3 - Irish Residential Properties REIT plc
-
McEwen Mining Announces Closing of Flow-Through Financing
-
Monte Rosa Therapeutics Presents Preclinical Data at EULAR 2024 Demonstrating Therapeutic Potential of MRT-6160 for the Treatment of Rheumatoid Arthritis
-
OneMedNet Partners with Leading Clinical Trial Design and Software Company in Significant Data License Agreement
-
Alliance Trust PLC - Net Asset Value
-
GenTwo and issuance.swiss, powered by Apex Group, Forge Strategic Partnership for Digital Assets AMC and ETP Issuance
-
Baltic Horizon Fund plans to redeem early part of the bonds
-
SECU Awarded PLANSPONSOR of the Year for Its Total Retirement Offering for Employees
-
Landsbankinn hf.: Covered bond exchange offering results
-
Invesco Ltd: Form 8.3 - Quanex Building Products Corporation
-
Golden Triangle Ventures Announces Launch of Its Freight Brokerage Division with Full Financial Support
-
SRIVARU (SVMH) Announces PRANA 2.0 Electric Motorbike will be Available to Order Online Beginning June 16th with First Shipments to Commence in early Q3 2024
-
Chijet Motor Company, Inc.’s Subsidiary Entered Into Framework Cooperation Agreement with Uzbekistan Customer
-
FOXO Technologies Enters into Share Exchange Agreements to Acquire Healthcare Operations from Rennova Health, Inc.
-
Invesco Ltd: Form 8.3 - International Paper Company Public dealing disclosure
-
Invesco Ltd: Form 8.3 - DS Smith PLC
-
Sienna Announces June Dividend
-
Borregaard ASA: Issuance of Commercial Paper
-
Kuke and Jidou Join Forces in the AI Music Market
-
Progressive Reports May 2024 Results
-
Diana Shipping Inc. Announces Time Charter Contract for m/v Myrsini With Cobelfret S.A.
-
GRI Bio Announces Reverse Stock Split
-
Disc Medicine Announces Underwritten Offering of Common Stock
-
ElmediX Plans Series A Round Based on Strong Signals in a Clinical Study for Pancreatic Cancer Patients at the University Hospital Antwerp (Belgium)
-
Jasper Therapeutics Presents Data from Preclinical Briquilimab Study at the 2024 EHA Hybrid Congress
-
UPCX: Redefining Future Payments and Financial Services Based on Graphene
-
BIO-key Introduces Passkey:YOU, a Phish-resistant, Phoneless and Tokenless Biometric FIDO Passkey Authentication Solution
-
Summit Nanotech and Zelandez Collaborate to Accelerate Modular Lithium Carbonation Project in South America
-
ORYZON Presents Preliminary Data From Ongoing Phase Ib FRIDA Trial with Iadademstat Plus Gilteritinib in Relapsed/Refractory FLT3-mut AML Patients at EHA-2024
-
Mineralys Therapeutics Appoints Biopharmaceutical Executive Alexander M. Gold, M.D. to its Board of Directors
-
Findings on the Burdens of Diabetic Peripheral Neuropathic Pain (DPNP) Among Three Lexicon-Sponsored Presentations at the 84th Scientific Sessions of the American Diabetes Association
-
Hurco Companies, Inc. Announces Suspension of Quarterly Cash Dividend
-
STRATTEC SECURITY CORPORATION names senior automotive parts executive as CEO
-
Sharecare wins 22 Digital Health Awards in Spring 2024 competition
-
Gorilla Technology to Participate in Water Tower Fireside Chat Series
-
BetterLife Announces Closing of a Private Placement
-
LiveOne (Nasdaq: LVO) Announces 244th Edition of LiveOne Presents as Streaming Partner for “The Game of Legends” from Culture by Futbol
-
Spectrum Group International Announces Extension of Election Deadline for Proposed Cash Election Merger
-
GRANITESHARES HITS $6 BILLION AUM AS NVDL SURGES
-
Aktsiaselts Infortar signed an agreement for selling a shareholding at subsidiary
-
Subsea7 awarded a contract for the Bittern field in the UK North Sea
-
Share repurchase programme
-
Mereo BioPharma Announces Pricing of $50 Million Underwritten Registered Direct Offering of American Depository Shares, Priced At-the-Market
-
Treasure Global Inc Announces New Chief Executive Officer
-
Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Association (EHA) 2024 Hybrid Congress
-
Intellia Therapeutics Names Brian Goff to its Board of Directors
-
Cogent Biosciences Announces Additional Clinical Data from Part 1 of its Ongoing SUMMIT Trial Evaluating Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM)
-
JOYY Inc. Announces the Results of the Repurchase Right Offer for its 1.375% Convertible Senior Notes due 2026
-
Plato Gold Welcomes Mr. Ernie J. Marcotte to the Board of Directors
